메뉴 건너뛰기




Volumn 23, Issue 3, 2012, Pages 264-268

The use of dabigatran immediately after atrial fibrillation ablation

Author keywords

anticoagulation; atrial fibrillation; catheter ablation; dabigatran; pulmonary vein isolation; stroke

Indexed keywords

ACETYLSALICYLIC ACID; DABIGATRAN; ENOXAPARIN; WARFARIN;

EID: 84858618101     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02175.x     Document Type: Article
Times cited : (120)

References (21)
  • 2
    • 79953248796 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes M, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM,: 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm 2011; 8: 157-176.
    • (2011) Heart Rhythm , vol.8 , pp. 157-176
    • Wann, L.S.1    Curtis, A.B.2    January, C.T.3    Ellenbogen, K.A.4    Lowe, J.E.5    Estes, M.6    Page, R.L.7    Ezekowitz, M.D.8    Slotwiner, D.J.9    Jackman, W.M.10    Stevenson, W.G.11    Tracy, C.M.12
  • 4
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial Fibrillation
    • Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ,: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 2010; 137: 263-272.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.H.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 6
    • 79960184734 scopus 로고    scopus 로고
    • Long term results of atrial fibrillation ablation: The importance of all initial ablation failures undergoing a repeat ablation
    • Winkle RA, Mead RH, Engel G, Patrawala RA,: Long term results of atrial fibrillation ablation: The importance of all initial ablation failures undergoing a repeat ablation. Am Heart J 2011; 162: 193-200.
    • (2011) Am Heart J , vol.162 , pp. 193-200
    • Winkle, R.A.1    Mead, R.H.2    Engel, G.3    Patrawala, R.A.4
  • 8
    • 79951577921 scopus 로고    scopus 로고
    • Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture
    • Winkle RA, Mead RH, Engel G, Patrawala RA,: Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture. Am J Cardiol 2011; 107: 704-708.
    • (2011) Am J Cardiol , vol.107 , pp. 704-708
    • Winkle, R.A.1    Mead, R.H.2    Engel, G.3    Patrawala, R.A.4
  • 10
    • 84855512502 scopus 로고    scopus 로고
    • The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation
    • Winkle RA, Mead RH, Engel G, Patrawala RA,: The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm 2011;8:1411-1415.
    • (2011) Heart Rhythm , vol.8 , pp. 1411-1415
    • Winkle, R.A.1    Mead, R.H.2    Engel, G.3    Patrawala, R.A.4
  • 11
    • 79957564461 scopus 로고    scopus 로고
    • Atrial fibrillation ablation: Perpetual motion of open irrigated tip catheters at 50 watts is safe and improves outcomes
    • Winkle RA, Mead RH, Engel G, Patrawala RA,: Atrial fibrillation ablation: Perpetual motion of open irrigated tip catheters at 50 watts is safe and improves outcomes. Pacing Clin Elecrophysiol 2011; 34: 531-539.
    • (2011) Pacing Clin Elecrophysiol , vol.34 , pp. 531-539
    • Winkle, R.A.1    Mead, R.H.2    Engel, G.3    Patrawala, R.A.4
  • 12
    • 49149130353 scopus 로고    scopus 로고
    • Dabigatran etexilate
    • Sanford M, Plosker GL,: Dabigatran etexilate. Drugs 2008; 68: 1699-1709.
    • (2008) Drugs , vol.68 , pp. 1699-1709
    • Sanford, M.1    Plosker, G.L.2
  • 13
    • 79251624660 scopus 로고    scopus 로고
    • Dabigatran etexilate. A review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation
    • Garnock-Jones KP,: Dabigatran etexilate. A review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation. Am J Cardiovasc Drugs 2011; 11: 57-72.
    • (2011) Am J Cardiovasc Drugs , vol.11 , pp. 57-72
    • Garnock-Jones, K.P.1
  • 14
    • 41949116970 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
    • DOI 10.2165/00003088-200847050-00001
    • Stangier J,: Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 2008; 47: 285-295. (Pubitemid 351508116)
    • (2008) Clinical Pharmacokinetics , vol.47 , Issue.5 , pp. 285-295
    • Stangier, J.1
  • 15
    • 34548031359 scopus 로고    scopus 로고
    • The pharmacokinetic, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
    • Stangier J, Rathgen K, Stähle H, Gansser D, Roth W,: The pharmacokinetic, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol 64: 292-303.
    • Br J Clin Pharmacol , vol.64 , pp. 292-303
    • Stangier, J.1    Rathgen, K.2    Stähle, H.3    Gansser, D.4    Roth, W.5
  • 16
    • 37149005153 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects
    • Stangier J, Stähle H, Rathgen K, Fuhr R,: Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects. Clin Pharmacokinet 2008; 47: 47-59. (Pubitemid 350260888)
    • (2008) Clinical Pharmacokinetics , vol.47 , Issue.1 , pp. 47-59
    • Stangier, J.1    Stahle, H.2    Rathgen, K.3    Fuhr, R.4
  • 17
    • 77949421739 scopus 로고    scopus 로고
    • Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate. An open-label, parallel-group, single-centre study
    • Stangier J, Rathgen K, Stähle H, Mazur D,: Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate. An open-label, parallel-group, single-centre study. Clin Pharmacokinet 2010; 49: 259-268.
    • (2010) Clin Pharmacokinet , vol.49 , pp. 259-268
    • Stangier, J.1    Rathgen, K.2    Stähle, H.3    Mazur, D.4
  • 18
    • 17644400166 scopus 로고    scopus 로고
    • Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement
    • DOI 10.1177/0091270005274550
    • Stangier J, Eriksson BI, Dahl OE, Ahnfelt L, Nehmiz G, Stähle H, Rathgen K, Svärd R,: Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. J Clin Pharmacol 2005; 45: 555-563. (Pubitemid 40562946)
    • (2005) Journal of Clinical Pharmacology , vol.45 , Issue.5 , pp. 555-563
    • Stangier, J.1    Eriksson, B.I.2    Dahl, O.E.3    Ahnfelt, L.4    Nehmiz, G.5    Stahle, H.6    Rathgen, K.7    Svard, R.8
  • 19
    • 17644409026 scopus 로고    scopus 로고
    • A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: The BISTRO II randomized trial
    • DOI 10.1111/j.1538-7836.2004.01100.x
    • Ericksson BI, Dahl OE, Büller HR, Hettiarachchi R, Rosencher N, Bravo ML, Ahnfelt L, Piovella F, Stangier J, Kälebo P, Reilly P,; for the BISTRO II Study Group: A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: The BISTRO II randomized trial. J Thromb Haemost 2005; 3: 103-111. (Pubitemid 41647122)
    • (2005) Journal of Thrombosis and Haemostasis , vol.3 , Issue.1 , pp. 103-111
    • Eriksson, B.I.1    Dahl, O.E.2    Buller, H.R.3    Hettiarachi, R.4    Rosencher, N.5    Bravo, M.-L.6    Ahnfelt, L.7    Piovella, F.8    Stangier, J.9    Kalebo, P.10    Reilly, P.11
  • 21
    • 80051800555 scopus 로고    scopus 로고
    • New anticoagulants for prevention of stroke in patients with atrial fibrillation
    • Viles-Gonzales JF, Fuster V, Halperin JL,: New anticoagulants for prevention of stroke in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 948-955.
    • (2011) J Cardiovasc Electrophysiol , vol.22 , pp. 948-955
    • Viles-Gonzales, J.F.1    Fuster, V.2    Halperin, J.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.